This website is being retired.
Content is no longer being updated from 31 March 2026. Find out more.
This website is being retired.
Content is no longer being updated from 31 March 2026. Find out more.
Transformation Directorate
This guidance has been reviewed by the Health and Care Information Governance Working Group, including the Information Commissioner's Office (ICO) and National Data Guardian (NDG).
Have we done a good job? Let us know.
First published on 27 June 2025.
Last updated on 21 January 2026.
This guidance provides advice on information sharing with the Infected Blood Compensation Authority (IBCA) to support claims from those who have been impacted.
IBCA is an independent arms-length body set up to pay compensation to people infected and affected by HIV, hepatitis B and C through contaminated blood, blood products or tissue following the Infected Blood Inquiry.
To process the claims of those impacted by contaminated blood, blood products or tissue, IBCA may approach NHS organisations for evidence for a specific person claiming compensation.
Many of the people claiming compensation will have been waiting many years for compensation and some will be nearing end of life. Organisations are expected to manage any correspondence from IBCA promptly.
The IBCA website includes the following information to support you making a claim for compensation:
The IBCA website provides details of the documents you may need to support your claim. This includes documents to prove who you are.
Information from your medical records may be needed to support your claim. If you are claiming compensation on behalf of someone who has died, information from that person’s medical records may be needed. IBCA knows that you may not have this information yourself. When you start your claim, your dedicated claim manager will guide you through what's needed.
If you already have the medical records, you can choose to share them with IBCA. If not, you don't have to find the information yourself. IBCA will contact the organisations that hold the records to ask for the medical information they need.
Organisations will only share information that is relevant to your claim with IBCA. This could include:
Where you are claiming on behalf of someone who has died, it will be their information requested rather than your own.
You do not need to do anything to ensure that the NHS provides this medical information to IBCA. IBCA will contact the NHS organisations that have provided you (or, where relevant the person who infected you) with care and ask them for the information.
NHS organisations are legally required to provide the information to IBCA. They do not need to ask for your consent before sending the information, even if the information is confidential. If you were infected by someone else, rather than through NHS treatment, the NHS also does not need that person’s consent if it is relevant to your claim. This ensures that your claim is dealt with as quickly as possible.
IBCA will only use information to support your claim. If it wishes to use it for something else, they will have to ask you first. You can read more about how IBCA uses information in their privacy notice.
The Inquiry is funding a confidential support service for anyone affected by treatment with infected blood or blood products. Information that you share with the support service is not made available to IBCA.
The NHS is required by law to share information with IBCA to support claims, so you cannot object to this. Your claims manager at IBCA will discuss what information may be needed to support your claim, and you should raise any concerns with them. You can object to IBCA holding and using the information. To do this, you can contact ibca.datagov@ibca.org.uk. IBCA will consider your request, but this may make it more difficult for you to claim compensation.
You can read more about how the scheme will work on the IBCA website.
NHS England does not hold any information about your claim so will not be able to answer any questions related to this. You can direct any questions to IBCA by emailing ibcaenquiries@ibca.org.uk.
Your organisation will nominate a single point of contact who will coordinate and manage requests for information from IBCA.
To process the claims of those impacted by contaminated blood, blood products or tissue, you may be asked to provide evidence for a specific person claiming compensation. This could be someone you have cared for but could also relate to someone who was cared for by a clinical colleague who previously worked at your organisation.
IBCA will have a body of evidence required for each claim, some of which will be provided by the person claiming compensation. Where gaps in evidence are identified, IBCA will need to obtain copies of any evidence required.
You will be provided with the necessary details of the person claiming compensation and the information required. Whilst this will vary for each claim, common types of information requested include:
Such as:
Such as
Evidence that diagnosis has (or has not) progressed and the date that these changes happened – severity levels are provided by IBCA when requesting information, for example hepatitis C only is defined as severity level 1 and hepatitis B only is defined as severity level 5
If the exact evidence cannot be sent, a written statement with a timeline of events can be accepted if it has been signed off by an appropriate clinician.
Patients who are nearing the end of their life may also ask IBCA to consider their claim more urgently. Read the information published by IBCA. IBCA may therefore also ask you to provide information to confirm that this is the case for a patient.
Patient consent is not required before sharing information with IBCA for the administration of claims (see Legal basis for sharing in the IG Professionals section below for further information). This includes when providing information to support the claim of someone who has been indirectly infected. For example you do not need consent to share information from a patient’s records to support a claim from that patient’s infected partner.
Your organisation’s single point of contact should respond to IBCA within 7 working days, providing:
Where a person claiming compensation is nearing the end of their life, IBCA will confirm this in their request, and such requests should be dealt with as a priority.
If you require any further support, contact your IG team or Data Protection Officer (DPO). Your Caldicott Guardian can also provide advice if you have questions.
You should nominate a single point of contact for IBCA to contact in relation to any requests for information relating to compensation claims and send this to ibca.datagov@ibca.org.uk. The single point of contact should be someone who can respond to IBCA within 7 working days, providing:
You will need to consider within your organisation who is best placed to be the single point of contact, and this is likely to vary from one organisation to another. For example, for some trusts the subject access request (SAR) team may be best placed to manage the request (although requests from IBCA should not be processed as SAR requests, see Legal basis for sharing section below), whereas for others the DPO may wish to coordinate.
For DPOs that support GP practices, you will need to consider who the single point of contact is for the GP practices you support. This could be a single point of contact for each practice or one individual who coordinates for multiple practices.
Once the single point of contact is confirmed, they will need to work through the processes within your organisation for gathering the requested information.
IBCA has been created through the Victims and Prisoners Act 2024 (VAP), which sets out its duties and obligations.
Section 53 of the VAP provides IBCA with the legal power to require information from NHS organisations when needed to process an infected blood compensation claim.
It also provides NHS providers with a legal power to provide information to IBCA for the purposes of any matter connected with the administration of the compensation scheme, which includes personal data such as medical records or information. The Act imposes a duty upon NHS providers to comply with requests for information from IBCA. Section 53 also allows IBCA to seek a court order in the event a notice to provide information is not complied with.
The requirement to send information to IBCA is not therefore a subject access request on behalf of the patient, or a request under the Access to Health Records Act where the patient is deceased, but a request for information using the statutory powers of the VAP.
Section 53 of the VAP sets aside the common law duty of confidentiality and gives you the legal power to provide the information to IBCA upon request. This includes information relating to deceased individuals where someone is making a claim on their behalf. This means that you do not need the consent of the patient to share information with IBCA. You also do not need a patient’s consent to share information from their records to support the claim of someone who has been indirectly infected, such as a current or former partner.
Under UK GDPR the legal bases which are most likely to apply are:
Article 6 (1) (c) legal obligation: to comply with a requirement to provide information under section 53(2) of the VAP.
Article 9 (2) (g) substantial public interest: processing is necessary for reasons of substantial public interest, on the basis of domestic law which shall be proportionate to the aim pursued, respect the essence of the right to data protection and provide for suitable and specific measures to safeguard the fundamental rights and the interests of the data subject.
The relevant Schedule 1 condition in the Data Protection Act 2018 is part 2 paragraph 6: the purpose of sharing is the exercise of a function conferred on a person by an enactment or rule of law.
Correspondence from IBCA should not be treated as a subject access request, or a request under the Access to Health Records Act where the patient is deceased (see Legal basis for sharing section).
Patients will be asked to provide medical information to their claim managers where they hold it. They will not be asked by IBCA to contact you directly to request their information, although this does not prevent an individual, or a legal representative on their behalf, submitting a subject access request.
You should add information about these sharing requirements with IBCA in your privacy notice and signpost to IBCA’s privacy notice so that patients can find out more about this sharing.
NHS England has developed a privacy notice template that you can use to develop your wider privacy notices, and some recommended wording below that you can include:
If you have made a claim for compensation through the Infected Blood Compensation Authority (IBCA), [your organisation name] may provide IBCA with relevant information from your medical records (and, where relevant the person who infected you) to support your claim.
You can read more about how IBCA uses your information in their privacy notice.
You can also refer individuals to the patient section of this guidance.
IBCA will have a body of information required for each claim, some of which will be provided by the person claiming compensation.
Where gaps in evidence are identified, IBCA will contact your single point of contact to obtain copies of any evidence required. They will be provided with the necessary details of the person claiming compensation and the information required.
The single point of contact will consider how best to source the information requested (see the common types of information requested paragraph of the Guidance for healthcare workers section above for further information).
At this time, IBCA is processing the claims of individuals who have chosen to register with the 4 national Infected Blood Support Schemes (IBSS). You do not require any further evidence that IBCA is acting on behalf of the person claiming compensation given that individuals have decided to apply for these schemes and IBCA would not be processing a claim without their authorisation.
IBCA has processes in place to verify the identity of the individual. This includes checking identity documents from the person claiming compensation. You should not therefore repeat this process with the patient.
All correspondence from IBCA will come from an email address ending in ibca.org.uk. IBCA has been assigned an Organisation Data Service (ODS) code of Y2Y5B – INFECTED BLOOD COMPENSATION AUTHORITY.
Correspondence from IBCA will set out clearly their powers for requiring their information.
If you have any questions about the request itself, for example if your records had slightly different details to the information requested you should contact the claim manager for clarification. You should also speak to your Caldicott Guardian if you have any concerns.
It is important to provide information to IBCA as soon as possible to avoid any delay to a claim for compensation. Where a person claiming compensation is nearing the end of their life, IBCA will confirm this in their request, and such requests should be dealt with as a priority. The single point of contact should respond to IBCA within 7 working days, providing:
Whilst recognising that organisations are managing multiple requests for information simultaneously which can create a significant burden, your support in responding to correspondence from IBCA promptly would be valued.
IBCA will ensure that their processes and sharing are compliant by:
IBCA has put in place security measures to ensure the security of the information they receive. These include:
For most cases, IBCA will retain the information they receive for 8 years. There may be exceptions to this for example where there was a late diagnosis. IBCA will delete the copies of information it holds at the end of the retention period.
It is good practice to document this data sharing on your organisation’s information asset and data flow register.
NHS England guidance on the importance of retaining information that might be required in connection with the Infected Blood Compensation Scheme and support schemes.
First published on 27 June 2025.
To include guidance about claims from people who have been indirectly infected, for example by someone else rather than through receiving NHS treatment.
To include guidance about claims involving people who are deceased.